“In murine bone marrow-derived DCs, dexmedetomidine significantly delayed the intracellular proteolytic degradation of ovalbumin , while it did not affect phagocytosis, decreased the expression of the surface molecules I-Ab and CD86, and suppressed cognitive helper T-cell proliferation.”